Filing Details

Accession Number:
0001209191-16-146640
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-10-21 18:18:40
Reporting Period:
2016-10-19
Filing Date:
2016-10-21
Accepted Time:
2016-10-21 18:18:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1044378 Biocept Inc BIOC Services-Medical Laboratories (8071) 330757995
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591395 Alpert Marsha Chandler C/O Biocept, Inc.
5810 Nancy Ridge Drive #150
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-04 1,693 $0.00 667 No 4 G Direct
Common Stock Acquisiton 2014-03-04 1,693 $0.00 1,693 No 4 G Indirect By trust
Common Stock Acquisiton 2016-10-19 4,545 $1.10 5,212 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 G Direct
No 4 G Indirect By trust
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2016-10-19 4,545 $0.00 4,545 $1.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,545 2016-10-19 2021-10-19 No 4 P Direct
Footnotes
  1. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 1,333 fewer shares with respect to these shares.
  2. On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 3,385 fewer shares with respect to these shares.
  3. Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.